CAPREOMYCIN SULFATE Drug Patent Profile
✉ Email this page to a colleague
When do Capreomycin Sulfate patents expire, and when can generic versions of Capreomycin Sulfate launch?
Capreomycin Sulfate is a drug marketed by Hisun Pharm Hangzhou and Mylan Labs Ltd and is included in two NDAs.
The generic ingredient in CAPREOMYCIN SULFATE is capreomycin sulfate. There are three drug master file entries for this compound. Additional details are available on the capreomycin sulfate profile page.
Summary for CAPREOMYCIN SULFATE
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 8 |
| Clinical Trials: | 1 |
| Patent Applications: | 1 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | CAPREOMYCIN SULFATE at DailyMed |
Recent Clinical Trials for CAPREOMYCIN SULFATE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| National Institute of Allergy and Infectious Diseases (NIAID) | N/A |
Medical Subject Heading (MeSH) Categories for CAPREOMYCIN SULFATE
Anatomical Therapeutic Chemical (ATC) Classes for CAPREOMYCIN SULFATE
US Patents and Regulatory Information for CAPREOMYCIN SULFATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hisun Pharm Hangzhou | CAPREOMYCIN SULFATE | capreomycin sulfate | INJECTABLE;INJECTION | 204796-001 | Oct 18, 2018 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Mylan Labs Ltd | CAPREOMYCIN SULFATE | capreomycin sulfate | INJECTABLE;INJECTION | 202634-001 | Nov 27, 2017 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
